Asplenia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Template) |
||
Line 19: | Line 19: | ||
==[[Asplenia historical perspective|Historical Perspective]]== | ==[[Asplenia historical perspective|Historical Perspective]]== | ||
==[[Asplenia classification|Classification]]== | |||
==[[Asplenia pathophysiology|Pathophysiology]]== | ==[[Asplenia pathophysiology|Pathophysiology]]== | ||
Line 27: | Line 29: | ||
==[[Asplenia epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Asplenia epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Asplenia risk factors|Risk Factors]]== | |||
==[[Asplenia screening|Screening]]== | |||
==[[Asplenia natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[Asplenia natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
Line 32: | Line 38: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Asplenia history and symptoms|History and Symptoms]] | [[Asplenia physical examination|Physical Examination]] | [[Asplenia laboratory findings|Laboratory Findings]] | [[Asplenia x ray|X Ray]] | [[Asplenia CT|CT]] | [[Asplenia MRI|MRI]] | [[Asplenia echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Asplenia other imaging findings|Other Imaging Findings]] | [[Asplenia other diagnostic studies|Other Diagnostic Studies]] | [[Asplenia history and symptoms|History and Symptoms]] | [[Asplenia physical examination|Physical Examination]] | [[Asplenia laboratory findings|Laboratory Findings]] | [[Asplenia x ray|X Ray]] | [[Asplenia CT|CT]] | [[Asplenia MRI|MRI]] | [[Asplenia echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Asplenia other imaging findings|Other Imaging Findings]] | [[Asplenia other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[Asplenia medical therapy | [[Asplenia medical therapy|Medical Therapy]] | [[Asplenia surgery|Surgery]] | [[Asplenia primary prevention|Primary Prevention]] | [[Asplenia secondary prevention|Secondary Prevention]] | [[Asplenia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Asplenia future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[Asplenia case study one|Case #1]] | [[Asplenia case study one|Case #1]] |
Revision as of 19:39, 23 June 2016
Asplenia | |
ICD-10 | D73.0, Q89.0 |
---|---|
ICD-9 | 289.59, 759.01 |
OMIM | 208530 %271400 208540 |
Asplenia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Asplenia On the Web |
American Roentgen Ray Society Images of Asplenia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Asplenia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Template:Hematology Template:Phakomatoses and other congenital malformations not elsewhere classified